A bill to amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval.

Amends Federal law regarding extensions of pharmaceutical patent terms to permit a separate extension for a product subject to a regulatory review period before it is put into commerce if the patent claim covers more than one: (1) product; (2) method of product use; or (3) product manufacturing method.

Precludes the use of such extensions for a product other than the one for which the extension is sought.